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Purpose: To determine the feasibility and safety of robotic partial nephrectomy (RPN), 
we compared the operative outcomes of patients who had undergone RPN with those 
of patients who had undergone laparoscopic partial nephrectomy (LPN).
Materials and Methods: Between February 2009 and June 2010, 13 patients underwent 
transperitoneal RPN (group 1) and 14 patients underwent transperitoneal LPN (group 
2) by a single surgeon. The operative outcomes of the 2 groups were compared by using 
Mann-Whitney U and Fisher’s exact tests.
Results: All cases were completed successfully without conversion to open surgery. The 
mean operative time was 153.2±22.3 and 117.5±32.0 minutes in groups 1 and 2, re-
spectively (p=0.003). The mean robotic console time of group 1 was 101.2±21.5 minutes, 
and the mean laparoscopic time of group 2 was 86.8±32.3 minutes (p=0.139). The mean 
warm ischemic time was 35.3±8.5 minutes and 36.4±6.8 minutes in groups 1 and 2, 
respectively (p=0.823). The mean estimated blood loss was 283.6±113.5 ml and 264.1±
163.7 ml (p=0.382), respectively. The mean length of hospital stay was 6.1 and 5.3 days 
(p=0.290), respectively. The mean tumor size was 2.7±1.2 cm and 2.0±1.2 cm (p=0.035), 
respectively. The surgical margins were negative in all cases.
Conclusions: Although the operative time of RPN was longer than that of LPN, there 
were no significant differences in operative outcomes including robotic console time and 
laparoscopic time between the procedures.
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INTRODUCTION
Nephron-sparing treatments have been considered as the 
best therapeutic strategy for localized renal cell carcinoma 
(RCC), and these procedures have gained popularity [1]. 
The application of renal ablative treatments, including ra-
diofrequency ablation and cryoablation, has been increa-
sing. These approaches preserve renal function, shorten 
the duration of hospital stay, and result in early convale-
scence. However, these treatments have limitations such 
as the lack of pathologic tumor assessment and uncertain 
long-term oncologic outcomes [2]. The use of partial neph-
rectomy has also increased. Although its oncological out-
comes are equivalent to those of radical nephrectomy for 
localized RCC, partial nephrectomy has advantages over 
radical nephrectomy [3-5]. Patients undergoing radical 
nephrectomy have a significantly higher chance of develop-
ing chronic renal insufficiency than do those undergoing 
partial nephrectomy. The incidence of renal insufficiency 
over time is significantly greater in patients undergoing 
radical nephrectomy.  
　Laparoscopic partial nephrectomy (LPN) is a less in-
vasive procedure than open surgery. However, it remains 
a challenging procedure for surgeons without considerable 
laparoscopic experience. Recently, robotic surgery has 
found wide applications in the urology field. It allows sur-
geons to perform difficult operations such as partial 
nephrectomy. Herein, we present our early experiences of 
robotic partial nephrectomy (RPN) procedures performed 
at our institution and compare the operative outcomes of Korean J Urol 2011;52:279-283
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FIG. 1. Port sites of robotic partial neph-
rectomy for a left tumor (A) and a right
upper pole tumor (B) in a 70-degree 
lateral position. 
FIG. 2. Operative findings. (A) Recons-
tructive suture for an opened calyx 
(arrow). (B) Application of a fibrin seal-
ant (arrow head) after continuous su-
ture using Hem-o-lok clips (arrow).
RPN with those of LPN.
MATERIALS AND METHODS
Between February 2009 and June 2010, 13 patients under-
went transperitoneal RPN (group 1) and 14 patients under-
went transperitoneal LPN (group 2) by a single surgeon. 
The patients were diagnosed with RCC or angiomyolipoma 
(AML) indistinguishable from RCC in radiologic studies. 
The operative methods were chosen after obtaining in-
formed consent and agreement for the charges for the oper-
ations from the patients. RPN was performed with the da 
Vinci S
Ⓡ system (Intuitive Surgical, Sunnyvale, CA, USA). 
In case of a centrally located tumor, a ureteral stent was 
inserted before the operation. The patients were placed in 
a 70-degree lateral position under 14 mmHg of CO2 gas 
insufflation. Usually, 3 robotic ports and 1 assistant port 
were used. In cases of a tumor in the upper pole of the right 
kidney, an additional robotic trocar (the third robotic arm) 
was placed to retract the liver (Fig. 1). In addition, a 30-degree, 
10 mm robotic camera was used. The patient cart with ro-
botic arms approached the patient posteriorly. It was 
docked at a 15-degree angle toward the head of the patient. 
　The operative techniques of RPN were similar to those 
of conventional LPN. A warm ischemia was achieved by 
placing laparoscopic bulldog clamps at the renal artery. 
The renal vein was not clamped. Before tumor excision, 
12.5 g of mannitol was administered intravenously. The re-
nal tumor was excised approximately 0.5 cm away from the 
normal tissue. After removal of the tumor, a frozen biopsy 
of the tumor bed was performed. The bleeding sites were 
controlled by electric coagulation. The damaged renal pel-
vocaliceal system was repaired with absorbable Vicryl
Ⓡ 3-0 
suture. The renal parenchyma with capsule was sutured 
with Vicryl
Ⓡ 2-0 attached to Hem-o-lok
Ⓡ clips (Weck clo-
sure systems, Research Triangle Park, NC, USA). The con-
tinuous suture was initiated from outside the renal paren-
chyma and continued to compress the renal parenchyma. 
Hem-o-lok clips were placed after each throw of the running 
suture. Finally, absorbable clips (Lapra-Ty
Ⓡ, Ethicon Inc., 
Somerville, NJ, USA) were applied instead of tying knots 
(Fig. 2). After confirmation of hemostasis, a fibrin sealant 
(Tisseel
Ⓡ, Baxter AG, Vienna, Austria) and a cellulose 
mesh (Surgicel
Ⓡ, Ethicon Inc., Somerville, NJ, USA) were 
placed on the suture sites. The bulldog clamps were 
removed. After confirmation of hemostasis, fascial suture 
with Vicryl
Ⓡ 3-0 was performed. A Jackson-Pratt drain was 
inserted in the operative field. The excised specimen in the 
laparoscopic pouch was removed with a trocar.
　The patients’ records were reviewed retrospectively. To 
compare the operative results of the 2 groups, the Mann- 
Whitney U test and Fisher’s exact test were used. The anal-
ysis was performed by using the SPSS ver. 18.0 (SPSS Inc., 
Chicago, IL, USA), with p-values＜0.05 considered to in-Korean J Urol 2011;52:279-283
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TABLE 1. Demographic parameters of patients
Parameters Group 1 Group 2 p-value
No. of patients 13 14
Mean age (yr) 54.2±12.4 (range, 33-72) 53.9±11.6 (range, 34-72) 0.884
a
Male:Female (ratio) 10:3 8:6 0.420
b
Mean BMI (kg/m
2) 23.8±2.3 (range, 25.2-28.7) 24.6±2.7 (range, 20.1-28.8) 0.423
a
Abdominal operation history (%) 4 (30.8) 5 (35.7) 1.000
b
Tumor laterality 
　Left/Right side 4/9 10/4 0.057
b
Tumor location
　Upper/Mid/Lower pole 1/8/4 2/7/5 0.595
b
Tumor distribution
　Exophytic/Endophytic 6/7 10/4 0.252
b
Group 1: robotic partial nephrectomy, Group 2: laparoscopic partial nephrectomy, BMI: body mass index, 
a: Mann-Whitney U test, 
b:
Fisher’s exact test
TABLE 2. Operative outcomes
Parameters Group 1 Group 2 p-value
Mean operative time (min) 153.2±22.3 (range, 110-200)  117.5±32.0 (range, 71-190) 0.003
a
Mean console or laparoscopic time (min) 101.2±21.5 (range, 60-150)   86.8±32.3 (range, 41-160) 0.139
a
Mean warm ischemic time (min) 35.3±8.5 (range, 30-47)   36.4±6.8 (range, 27-44) 0.823
a
Mean estimated blood loss (ml)     283.6±113.5 (range, 126.8-945.9)     264.1±163.7 (range, 63.4-718.6) 0.382
a
No. of transfusions (%) 2 (15.4) 0 (0) 0.222
b
Mean dosage of pethidine hydrochloride
for postoperative pain control (mg)
3.3±8.8 (range, 0-50) 3.5±12.0 (range, 0-50) 0.299
a
Mean time to postoperative  initiation of
ambulation (d)
1.2±0.4 (range, 1-2) 1.2±0.4 (range, 1-2) 0.920
a
Mean time to postoperative  initiation of
oral intake (d)
1.2±0.4 (range, 1-2) 1.1±0.3 (range, 1-2) 0.504
a
Mean duration of hospital stay (d) 6.2±1.8 (range, 5-10) 5.3±0.6 (range, 4-6) 0.290
a
Group 1: robotic partial nephrectomy, Group 2: laparoscopic partial nephrectomy, 
a: Mann-Whitney U test, 
b: Fisher’s exact test
dicate statistical significance.
RESULTS
The characteristics of the patients who underwent RPN 
(group 1) or LPN (group 2) are presented in Table 1. We found 
no significant differences between the 2 groups. Four cases 
(30.8%) in group 1 had a history of abdominal operations, 
including inguinal herniorrhaphy, laparoscopic hemi-
colectomy, appendectomy, and laparoscopic renal cyst 
excision. Five cases (35.7%) in group 2 had a history of ab-
dominal operations, including transvaginal hysterectomy, 
transabdominal hysterectomy, laparoscopic partial neph-
rectomy, and laparoscopic cholecystectomy. 
　All cases were completed successfully, without con-
version to laparoscopic or open surgery. The mean oper-
ative time was 153.2±22.3 minutes and 117.5±32.0 mi-
nutes in groups 1 and 2, respectively (p=0.003). The mean 
robotic console time of group 1 was 101.2±21.5 minutes, 
and the mean laparoscopic time of group 2 was 86.8±32.3 
minutes (p=0.139). The definition of the laparoscopic time 
was from insertion of the laparoscopic instruments to re-
moval of the instruments. Although the operative time of 
RPN was longer than that of laparoscopy, the differences 
in robotic console time and laparoscopic time were not 
significant. The mean warm ischemic time was 35.3±8.5 
minutes and 36.4±6.8 minutes in 9 patients of group 1 and 
10 patients of group 2, respectively (p=0.823). The mean es-
timated blood loss in groups 1 and 2 was 283.6±113.5 ml 
and 264.1±163.7 ml, respectively (p=0.382). Transfusion 
was performed in 2 patients (15.4%) in group 1 (p=0.222). 
There were no major complications in either group. 
Postoperative pain control was achieved by patient-control 
analgesia with morphine (40 mg) and ketorolac (150 mg) 
for 2 days. Additionally, pethidine HCl was administered 
at mean dosages of 3.3±8.8 mg and 3.5±12.0 in groups 1 and 
2, respectively (p=0.299). The mean times to postoperative 
initiation of ambulation were 1.2±0.4 days and 1.2±0.4 
days (p=0.920), and the times to initiation of oral intake 
were 1.2±0.4 days and 1.1±0.3 days (p=0.504) in groups 1 
and 2, respectively. The mean length of hospital stay in 
groups 1 and 2 was 6.2±1.8 days and 5.3±0.6 days, respec-
tively (p=0.290) (Table 2).
　The mean tumor size was 2.7±1.2 cm and 2.0±1.2 cm in 
groups 1 and 2 (p=0.035). Pathologic results showed 11 cases 
of RCC and 2 cases of AML in group 1, and 9 cases of RCC, Korean J Urol 2011;52:279-283
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TABLE 3. Pathologic results
Pathologic findings Group 1 Group 2 p-value
Mean tumor size (cm) 2.7±1.2
(range, 0.8-3.0)
2.0±1.2
(range, 1-6)
0.035
a
Pathologic results
Renal cell carcinoma 
(%)
11 (84.6) 9 (64.3) 0.785
b
Angiomyolipoma (%) 2 (15.4) 4 (28.6)
Oncocytoma (%) 0 (0) 1 (7.1)
Positive surgical 
margin (%)
0 (0) 0 (0)
Group 1: robotic partial nephrectomy, Group 2: laparoscopic parti-
al nephrectomy, 
a: Mann-Whitney U test, 
b: Fisher’s exact test
4 cases of AML, and 1 case of oncocytoma in group 2 (p=0.785). 
The surgical margins were negative in all cases (Table 3).
DISCUSSION
Open partial nephrectomy (OPN) is one of the standard mo-
dalities of nephron-sparing surgery. Long-term follow-up 
results of OPN for localized RCC have shown acceptable 
cancer control effects [6-8]. However, the postoperative re-
covery period of OPN is similar to that of open radical neph-
rectomy because of the morbidity due to the large flank 
incision. The number of LPNs has steadily increased since 
its introduction by Winfield et al in 1993 [9]. The techniques 
of LPN duplicate those of OPN. The indications are ex-
panded to more challenging cases, however, including cen-
tral and hilar tumors, endophytic tumors, tumors greater 
than 4 cm, tumors in solitary kidneys, and tumors in pa-
tients with compromised renal function [10,11]. Concer-
ning oncological outcomes, the 5-year cancer-specific sur-
vival rate for T1 RCC was more than 90% in a multicenter 
study [8,12,13]. 
　LPN has surgical and functional outcomes similar to 
those of OPN in addition to comparable oncological out-
comes. Gill et al presented a comparative study of LPN and 
OPN, in which LPN had shorter operating time, less esti-
mated blood loss, shorter hospital stay, and longer warm 
ischemic time [12]. Marszalek et al demonstrated that LPN 
had shorter warm ischemic time, hospital stay, and operat-
ing time in 200 patients undergoing either LPN or OPN 
[14]. These reports show that LPN is technically feasible. 
However, LPN still has a steep learning curve to overcome 
the technical challenges of complete tumor excision with 
hemostasis and renal reconstruction in a limited renal is-
chemic time.
　Robot-assisted laparoscopic surgery has been widely 
adapted. It can offer a magnified, three-dimensional view 
and fully-articulating wristed instruments and enables 
surgeons to perform difficult operations. RPN was in-
troduced by Gettman et al in 2004 [15]. Among the initial 
reports, Aron et al presented no proven advantages of RPN 
over LPN in 12 matched-pair patients [16]. However, due 
to advances in the surgical technique, favorable operative 
results and intermediate-term outcomes have been dem-
onstrated in recent reports. The operating time ranged 
from 83 to 197 minutes. The warm ischemic time ranged 
from 18 to 28 minutes. The estimated blood loss ranged 
from 133 to 198 ml. The duration of the hospital stay ranged 
from 1.9 to 5.2 days. The complication rate ranged from 0% 
to 17%. The positive surgical margin rate ranged from 0% 
to 2.3% [17-23]. RPN has advantages in the treatment of 
complex tumors such as endophytic, hilar, and multiple 
tumors. Rogers et al reported the feasibility of RPN for hilar 
tumors in 11 patients in a multi-institutional analysis [24]. 
Even though the feasibility and safety of RPN has been pro-
ven, it does have drawbacks, including the lack of haptic 
feedback, dependency on an assistant, and high operating 
costs. Long-term functional and oncological outcomes are 
needed to make RPN a standard treatment for small renal 
tumors.
　Our initial experience with RPN showed acceptable op-
erative outcomes comparable with those of previous re-
ports [15-23]. However, the mean hospital stay was prolon-
ged. One of the reasons was that the patients required a lon-
ger stay under the Korean health care system. We also pre-
sented the operative outcomes of RPN and LPN in this com-
parative study. Although the operative time of RPN was 
longer than that of LPN, there was no significant difference 
in robotic console time and laparoscopic time. It might take 
some time to connect the robotic surgical system to the pa-
tient in the RPN group. Unfortunately, the warm ischemic 
time was slightly long. The reasons for the long ischemic 
time might be the insertion time of suture materials and 
inexperienced assistants. We did frozen biopsy in most 
cases. If we had found a remnant cancer, we would have per-
formed a radical nephrectomy. Two patients in the RPN 
group had blood transfusions. They had intraperitoneal 
adhesions from previous abdominal operations, which led 
to incomplete arterial dissections and clampings and 
bleeding. 
　We did not find advantages in the operative results of 
RPN, which will require further accumulation of experi-
ence and technical developments. For example, our techni-
que for RPN had distinguishing operative features for 
hemostasis. We used a sliding-clip renorrhaphy for caly-
ceal reconstruction and parenchymal compression. When 
placing the Hem-o-lok clips, it is necessary to pull the su-
ture taut and then push the clip snug against the renal pa-
renchyma [25]. After completion of the suture and con-
firmation of hemostasis, a fibrin sealant and cellulose mesh 
were applied to the suture site. Finally, a third layer suture 
of the fascial covering was performed. This technique has 
certain advantages, including effective hemostasis, de-
creased dependence on assistance, and decreased oper-
ation and warm ischemic time [18,26].
　We acknowledge the limitations of this study. Our study 
was a retrospective analysis with a small number of patients. 
Furthermore, long-term follow-up is needed to identify on-
cologic and functional outcomes of RPN.Korean J Urol 2011;52:279-283
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CONCLUSIONS 
Our experiences showed that RPN was technically fea-
sible, and its operative outcomes were comparable to those 
of LPN. Although the operative time of RPN was longer 
than that of LPN, there was no significant difference in op-
erative outcomes, including robotic console time and lapa-
roscopic time. To identify advantages of RPN, we must ac-
cumulate more experience and make further technical 
developments. Further studies with long-term follow-up of 
RPN are also needed to make RPN a standard treatment 
for localized RCC.
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